Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 2/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.36 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | FPR2 | P25090 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4953190 | 1.00 | HDAC2 (0.40) | HDAC2NOD1TGM2SLC6A5ACHE | |
| SCHEMBL4955533 | 0.92 | HDAC2 (0.36) | HDAC2NOD1TGM2ALDH1A1FOLH1 | |
| SCHEMBL4955528 | 0.92 | HDAC2 (0.36) | HDAC2NOD1TGM2ALDH1A1FOLH1 | |
| SCHEMBL4955714 | 0.88 | ICMT (0.35) | HDAC2NOD1ALDH1A1 | |
| SCHEMBL4955720 | 0.88 | ICMT (0.35) | HDAC2NOD1ALDH1A1 | |
| SCHEMBL4954103 | 0.88 | HDAC2 (0.34) | HDAC2TGM2ALDH1A1FOLH1LMNA | |
| SCHEMBL4954095 | 0.88 | HDAC2 (0.34) | HDAC2TGM2ALDH1A1FOLH1LMNA | |
| SCHEMBL4952183 | 0.85 | HDAC2 (0.42) | HDAC2NOD1SLC6A5ACHEBACE1 | |
| SCHEMBL4952186 | 0.85 | HDAC2 (0.42) | HDAC2NOD1SLC6A5ACHEBACE1 | |
| SCHEMBL4955437 | 0.82 | LMNA (0.46) | ALDH1A1FOLH1CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7465471-B2 | Palatability of aquaculture feed | NOVUS INTERNATIONAL, INC. (US) | 2008-12-16 | — | — | US | disclosed |
| WO-2007147155-A1 | POLYOL ESTER COMPOUNDS | NOVUS INTERNATIONAL INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| US-20070292485-A1 | POLYOL ESTER COMPOUNDS | NOVUS INTERNATIONAL INC. (US) | 2007-12-20 | — | — | US | disclosed |
| US-20050215623-A1 | Palatability of aquaculture feed | NOVUS INTERNATIONAL, INC. (US) | 2005-09-29 | — | — | US | disclosed |
| US-20040175434-A1 | Antimicrobial compositions | NOVUS INTERNATIONAL, INC. | 2004-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292485-A1 | POLYOL ESTER COMPOUNDS | PNLIP, ELOVL1, ELOVL5 | HDAC2 708/4885NOD1 3692/4885TGM2 1022/4885 |
| US-20050215623-A1 | Palatability of aquaculture feed | TAS2R3, TAS2R1, TAS2R20 | HDAC2 1949/4885NOD1 3233/4885TGM2 1115/4885 |
| US-20040175434-A1 | Antimicrobial compositions | MRPL21, FPR1, ARG1 | HDAC2 2217/4885NOD1 10/4885TGM2 1530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.